Mr. Paul Reid:

One big qualifier we will always put on this is supply. In every week of the vaccination programme since 26 December, we have had interruptions in deliveries. In fairness to Pfizer and Moderna, they have been the firmest and strongest throughout. All our forecasts must have big qualifiers.